Back to Search Start Over

Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma

Authors :
Bandini, Marco
Ross, Jeffrey S.
Zhu, Yao
Ye, Ding-Wei
Ornellas, Antonio A.
Watkin, Nick
Ayres, Benjamin A.
Hakenberg, Oliver W.
Heidenreich, Axel
Salvioni, Roberto
Catanzaro, Mario
Raggi, Daniele
Giannatempo, Patrizia
Marandino, Laura
Haidl, Friederike
Pederzoli, Filippo
Briganti, Alberto
Montorsi, Francesco
Chipollini, Juan
Azizi, Mounsif
De Meerleer, Gert
Brouwer, Oscar R.
Grass, G. Daniel
Johnstone, Peter A.
Albersen, Maarten
Spiess, Philippe E.
Necchi, Andrea
Bandini, Marco
Ross, Jeffrey S.
Zhu, Yao
Ye, Ding-Wei
Ornellas, Antonio A.
Watkin, Nick
Ayres, Benjamin A.
Hakenberg, Oliver W.
Heidenreich, Axel
Salvioni, Roberto
Catanzaro, Mario
Raggi, Daniele
Giannatempo, Patrizia
Marandino, Laura
Haidl, Friederike
Pederzoli, Filippo
Briganti, Alberto
Montorsi, Francesco
Chipollini, Juan
Azizi, Mounsif
De Meerleer, Gert
Brouwer, Oscar R.
Grass, G. Daniel
Johnstone, Peter A.
Albersen, Maarten
Spiess, Philippe E.
Necchi, Andrea
Publication Year :
2021

Abstract

Background: Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node-involved penile squamous-cell carcinoma (PSCC) are lacking. Objective: To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status. Design, setting, and participants: In an international multicenter database of 1254 patients with PSCC who received inguinal lymph node dissection (ILND), 507 had suitable clinical information. Intervention: ILND, with or without chemotherapy or RT for involved lymph nodes. Outcome measurements and statistical analysis: Kaplan-Meier and restricted mean survival time (RMST) analyses for overall survival (OS) were performed for all patients and after propensity score-matching (PSM; n = 136), for which patient age, histology, type of penile surgical procedure, pathological tumor and nodal stage, ILND laterality, pelvic LND, and perioperative treatment were taken into account when assessing differences between HPV+ and HPV- patients. Finally, we looked at genomic alterations in PSCC using data from the Foundation Medicine database (n = 199) to characterize HPV+ PSCC. Results and limitations: Patients with HPV+ PSCC (n = 86; 17%) had lower clinical N stage (p < 0.001) and inguinal lymph node metastasis density (p < 0.001). Perioperative RT was delivered in 49 patients (9.7%), with the vast majority receiving adjuvant RT (n = 40). HPV+ patients had similar median OS (p = 0.1) but longer RMST than HPV- patients at different time points. Nevertheless, HPV+ patients treated with perioperative RT exhibited longer median OS (p = 0.015) and longer RMST compared to HPV- patients. In the PSM cohorts, HPV+ status remained significantly associated with longer OS after RT. The HPV- PSCC group had a higher frequency of TP53 mutations compared to HPV+ PSCC (75% vs 15%; p < 0.001). The results are limited by the retrospective nature of the data. Conclusions: Periopera

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1364970236
Document Type :
Electronic Resource